• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GNB1 通过靶向 BAG2 激活 P38/MAPK 信号通路促进肝癌进展。

GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling.

机构信息

Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

出版信息

Cancer Sci. 2023 May;114(5):2001-2013. doi: 10.1111/cas.15741. Epub 2023 Feb 14.

DOI:10.1111/cas.15741
PMID:36718954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10154882/
Abstract

G-proteins are intracellular partners of G-protein-coupled receptors. As a member of the G-protein family, GNB1 has been shown to play a pro-cancer role in lung cancer and breast cancer. However, the biological function and detailed mechanisms of GNB1 in hepatocellular carcinoma progression are unclear. In this study, we investigated the effects of GNB1 and its possible mechanism of action in hepatocellular carcinoma (HCC). The clinical significance of GNB1 was evaluated in a large cohort of HCC patients, showing that GNB1 was overexpressed in HCC compared to adjacent normal liver tissues, and increased GNB1 expression was associated with poor prognosis. We also demonstrated that GNB1 enhances cell proliferation, colony formation, and cell migration and invasion in vitro and promotes the epithelial-to-mesenchymal transition process in HCC cells. Tumor xenograft model assay confirmed the oncogenic role of GNB1 in tumorigenicity in nude mice. Activation of P38 signaling was found in the GNB1 overexpressed HCC cells. Further intervention of P38 confirmed it as an important signaling pathway for the oncogenic role of GNB1 in HCC. Moreover, co-immunoprecipitation followed by liquid chromatograph-mass spectrometry identified that GNB1 exerted oncogenic functions via the interaction of BAG2 and activated P38 signaling pathway. Together, our results reveal that GNB1 plays a pivotal oncogenic role in HCC by promoting the P38 pathway via cooperating with BAG2. GNB1 may serve as a prognostic biomarker for patients with HCC.

摘要

G 蛋白是 G 蛋白偶联受体的细胞内伴侣。作为 G 蛋白家族的一员,GNB1 已被证明在肺癌和乳腺癌中发挥致癌作用。然而,GNB1 在肝细胞癌进展中的生物学功能和详细机制尚不清楚。在这项研究中,我们研究了 GNB1 及其在肝细胞癌(HCC)中可能的作用机制。在大量 HCC 患者中评估了 GNB1 的临床意义,结果表明与相邻正常肝组织相比,GNB1 在 HCC 中过表达,并且 GNB1 表达增加与预后不良相关。我们还证明,GNB1 在体外增强了 HCC 细胞的增殖、集落形成和细胞迁移侵袭,并促进了 EMT 过程。肿瘤异种移植模型试验证实了 GNB1 在裸鼠致瘤性中的致癌作用。在 GNB1 过表达的 HCC 细胞中发现了 P38 信号的激活。进一步干预 P38 证实其是 GNB1 在 HCC 中致癌作用的重要信号通路。此外,免疫沉淀结合液质联用鉴定出 GNB1 通过与 BAG2 相互作用并激活 P38 信号通路发挥致癌功能。总之,我们的结果表明,GNB1 通过与 BAG2 合作促进 P38 通路在 HCC 中发挥关键致癌作用。GNB1 可能可作为 HCC 患者的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/5a6328124d31/CAS-114-2001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/d604ab22f9d2/CAS-114-2001-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/9d08a5f371e7/CAS-114-2001-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/bb6feeb2a1e1/CAS-114-2001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/801b996f4edb/CAS-114-2001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/278415f4fb80/CAS-114-2001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/5a6328124d31/CAS-114-2001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/d604ab22f9d2/CAS-114-2001-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/9d08a5f371e7/CAS-114-2001-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/bb6feeb2a1e1/CAS-114-2001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/801b996f4edb/CAS-114-2001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/278415f4fb80/CAS-114-2001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1eb/10154882/5a6328124d31/CAS-114-2001-g004.jpg

相似文献

1
GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling.GNB1 通过靶向 BAG2 激活 P38/MAPK 信号通路促进肝癌进展。
Cancer Sci. 2023 May;114(5):2001-2013. doi: 10.1111/cas.15741. Epub 2023 Feb 14.
2
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.LAGE3 通过促进 JNK 和 ERK 信号通路促进肝癌细胞的增殖、迁移和侵袭,抑制细胞凋亡。
Cell Mol Biol Lett. 2021 Nov 27;26(1):49. doi: 10.1186/s11658-021-00295-4.
3
CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.CD155/SRC 复合物通过抑制 p38 MAPK 信号通路促进肝癌进展,并与不良预后相关。
Clin Transl Med. 2022 Apr;12(4):e794. doi: 10.1002/ctm2.794.
4
Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.SLC46A3 的高表达可抑制肝细胞癌的进展及其对索拉非尼治疗的影响。
Biomed Pharmacother. 2019 Jun;114:108864. doi: 10.1016/j.biopha.2019.108864. Epub 2019 Apr 10.
5
BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.肝癌细胞 HepG2 分泌的 BMP2 通过激活 MAPK/p38 信号通路增强内皮细胞的血管生成和肿瘤生长。
Stem Cell Res Ther. 2019 Aug 6;10(1):237. doi: 10.1186/s13287-019-1301-2.
6
HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.HOXB7通过碱性成纤维细胞生长因子(bFGF)诱导的丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)途径激活促进肿瘤进展,并提示肝细胞癌预后不良。
Oncotarget. 2017 Jul 18;8(29):47121-47135. doi: 10.18632/oncotarget.17004.
7
Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.长链非编码 RNA LINC01503 通过激活 MAPK/ERK 通路促进肝癌的进展。
Int J Med Sci. 2020 May 18;17(9):1224-1234. doi: 10.7150/ijms.45256. eCollection 2020.
8
Bcl-2 Associated Athanogene 2 (BAG2) is Associated With Progression and Prognosis of Hepatocellular Carcinoma: A Bioinformatics-Based Analysis.Bcl-2 相关抗凋亡基因 2(BAG2)与肝细胞癌的进展和预后相关:基于生物信息学的分析。
Pathol Oncol Res. 2021 Apr 1;27:594649. doi: 10.3389/pore.2021.594649. eCollection 2021.
9
Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma.组织蛋白酶 C 通过与 TNF-α/p38 MAPK 信号通路相互作用促进肝癌的增殖和转移。
Cancer Res Treat. 2020 Jan;52(1):10-23. doi: 10.4143/crt.2019.145. Epub 2019 Apr 26.
10
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.长链非编码 RNA AGAP2-AS1 作为竞争性内源性 RNA,通过海绵吸附 miR-16-5p 而上调 ANXA11 的表达,促进肝癌的增殖和转移。
J Exp Clin Cancer Res. 2019 May 14;38(1):194. doi: 10.1186/s13046-019-1188-x.

引用本文的文献

1
Comprehensive analysis Neddylation-related genes identified UBB as a prognostic biomarker for clear cell renal cell carcinoma.对与Neddylation相关基因的综合分析确定了泛素B为透明细胞肾细胞癌的一种预后生物标志物。
Discov Oncol. 2025 May 22;16(1):859. doi: 10.1007/s12672-025-02547-7.
2
Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancer.全表观基因组分析揭示前列腺癌辐射诱导毒性风险的潜在生物标志物。
Clin Epigenetics. 2025 Mar 6;17(1):43. doi: 10.1186/s13148-025-01846-8.
3
Epigenetic mechanisms underlying endometrial cancer outcomes: race-specific patterns of DNA methylation associated with molecular subtypes and survival.

本文引用的文献

1
Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis.淋巴结比率可改善接受新辅助放化疗的食管癌患者的总生存预测:一项国家癌症数据库分析。
Ann Surg. 2023 Jun 1;277(6):e1239-e1246. doi: 10.1097/SLA.0000000000005450. Epub 2022 Jul 6.
2
Analysis of the risk factor of insufficient examined lymph nodes in stage II colon cancer from the perspective of stage migration: A retrospective study combined with external validation.从分期迁移角度分析Ⅱ期结肠癌淋巴结检查不足的危险因素:一项回顾性研究及外部验证
Int J Surg. 2022 May;101:106628. doi: 10.1016/j.ijsu.2022.106628. Epub 2022 Apr 19.
3
子宫内膜癌预后的表观遗传机制:与分子亚型和生存相关的种族特异性DNA甲基化模式
Carcinogenesis. 2025 Jan 20;46(1). doi: 10.1093/carcin/bgaf004.
4
Towards simplified graph neural networks for identifying cancer driver genes in heterophilic networks.迈向用于在异质网络中识别癌症驱动基因的简化图神经网络
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae691.
5
Genomic and Socioeconomic Determinants of Racial Disparities in Breast Cancer Survival: Insights from the All of Us Program.乳腺癌生存种族差异的基因组和社会经济决定因素:来自“我们所有人”计划的见解。
Cancers (Basel). 2024 Sep 27;16(19):3294. doi: 10.3390/cancers16193294.
6
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma.招募 BAG2 到 DNAJ-PKAc 支架中可促进纤维板层样肝癌细胞的存活和对药物诱导凋亡的抵抗。
Cell Rep. 2024 Feb 27;43(2):113678. doi: 10.1016/j.celrep.2024.113678. Epub 2024 Jan 17.
c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitro.
c-MYC-USP49-BAG2轴促进结直肠癌细胞在体外的增殖和化疗耐药性。
Biochem Biophys Res Commun. 2022 Jun 4;607:117-123. doi: 10.1016/j.bbrc.2022.03.138. Epub 2022 Mar 27.
4
Malignant progression of liver cancer progenitors requires lysine acetyltransferase 7-acetylated and cytoplasm-translocated G protein GαS.肝癌祖细胞的恶性进展需要赖氨酸乙酰转移酶 7 乙酰化和细胞质易位的 G 蛋白 GαS。
Hepatology. 2023 Apr 1;77(4):1106-1121. doi: 10.1002/hep.32487. Epub 2022 Apr 11.
5
An Insight into GPCR and G-Proteins as Cancer Drivers.G 蛋白偶联受体(GPCR)和 G 蛋白作为癌症驱动因素的深入了解。
Cells. 2021 Nov 24;10(12):3288. doi: 10.3390/cells10123288.
6
The emerging roles of Gα12/13 proteins on the hallmarks of cancer in solid tumors.Gα12/13 蛋白在实体瘤癌症特征中的新兴作用。
Oncogene. 2022 Jan;41(2):147-158. doi: 10.1038/s41388-021-02069-w. Epub 2021 Oct 23.
7
Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma.ATF3 诱导的 IL-6Rα 增强了肝癌细胞中 IL-6 介导的索拉非尼和regorafenib 耐药性。
Cancer Lett. 2022 Jan 1;524:161-171. doi: 10.1016/j.canlet.2021.10.024. Epub 2021 Oct 20.
8
Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer.利用乳腺癌患者中癌相关成纤维细胞和肿瘤细胞的BAG2表达进行转移风险评估
Cancers (Basel). 2021 Sep 16;13(18):4654. doi: 10.3390/cancers13184654.
9
Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.结直肠癌新型诊断和预后生物标志物:能够克服异质性特异性障碍,适用于全球应用。
PLoS One. 2021 Sep 2;16(9):e0256020. doi: 10.1371/journal.pone.0256020. eCollection 2021.
10
Bcl-2 Associated Athanogene 2 (BAG2) is Associated With Progression and Prognosis of Hepatocellular Carcinoma: A Bioinformatics-Based Analysis.Bcl-2 相关抗凋亡基因 2(BAG2)与肝细胞癌的进展和预后相关:基于生物信息学的分析。
Pathol Oncol Res. 2021 Apr 1;27:594649. doi: 10.3389/pore.2021.594649. eCollection 2021.